Back to search
FDAFDA · Food and drugs·Recall number D-1302-2020

oxyTOCIN 30 Units/500 mL (0.06 Units/mL) added to 0.9% Sodium Chloride Injection for IV Use, Rx only, QuVa Pharma 1075 West Park One Drive, Suite 100 Sugar Land, TX 77478 888-339-0874, NDC 70092-1068-07

Published June 17, 2020 · Recall initiated: May 28, 2020

Summary

FDA records drug Class II recall D-1302-2020, published June 17, 2020 and initiated May 28, 2020. Recalling firm: QuVa Pharma, Inc.; Status: Terminated; Reported quantity: 648 bags; Lot: Lot#: 30010515. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Subpotent drug - Product did not contain drug.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
QuVa Pharma, Inc.
Distributor
USA Nationwide
Lot
Lot#: 30010515
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was oxyTOCIN 30 Units/500 mL (0.06 Units/mL) added to 0.9% Sodium Chloride Injection for IV Use, Rx only, QuVa Pharma 1075 West Park One Drive, Suite 100 Sugar Land, TX 77478 888-339-0874, NDC 70092-1068-07 recalled?

Yes. FDA published recall D-1302-2020 on June 17, 2020. Reported hazard: Subpotent drug - Product did not contain drug.

What should I do if I have this product?

Voluntary: Firm initiated · Letter